It’s hard to escape hard levels of cholesterol, even though we keep away from foods that are rich in fats. Trans-fatty acids are everywhere, anywhere and anytime in our meals, stuffing our bellies with disposable fat and increasing the levels of cholesterol in our bodies. This could rapidly lead to heart diseases, diabetes and an extensive list of other affections that put our health at risk.
A team of researchers has managed to create an injectable drug called Praluent, developed by Regeneron Pharmaceuticals and approved by the FDA as the first one in a new class of drugs known under the name of PCSK9 inhibitors. According to the experts, the drug makes the liver work more efficiently and removes LDL-C or bad cholesterol. The low density lipoprotein cholesterol is one of the main building blocks of plaque formation in arteries.
In addition to diet and maximally tolerated stain therapy, the drug acts like a cure for people who need additional LDL cholesterol lowering. Praulent is dedicated to people with heterozygous hypercholesterolemia, a condition which is inherited and causes very high LDL cholesterol levels. Patients with clinical atherosclerotic cardiovascular disease can also benefit from the advantages of the injectable drug. Those who suffered a stroke or a cardiovascular attack are recommended to try out Praulent, which boosts levels of health and functionality at the arteries and heart level.
Praulent is the first efficient anti-cholesterol drug launched onto the market, successfully beating Repatha which is known to be a powerful medicine, having already secured the first European approval and expecting a US approval next month.
According to the experts, the drug “focuses on those who have truly had clinical disease or those who start out with such high levels of LDL they can’t get anywhere near where they should be”. This is good news for all the heart-affected people out there, who struggle to keep a healthy lifestyle in a world where food and life conditions will never be what they used to.
The new cholesterol drug approved by the FDA is dedicated to a large pool of patients who by now were unable to get their LDL levels lowered using the highly popular group of treatments known as statins. Although there are presently 7 such types of medicine on the market, they all fail to provide the levels of treatment to efficiently keep up with the need of affected individuals.
Image Source: phillyvoice.com